Tareq Abadl: Blood Unit Cross Matching – If Done Incorrectly… the Consequences Can Be Catastrophic
Dr. Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:
“Before a blood unit reaches the patient… one test stands as the final line of defense!
It’s called Cross Matching
If done incorrectly… the consequences can be catastrophic
What is Cross Matching?
Cross Matching is a mandatory pre-transfusion laboratory test performed before blood transfusion.
Its main goal is to ensure that:
Donor blood is fully compatible with the recipient’s blood
and that no immune reaction will occur that could destroy red blood cells.
Why is Cross Matching critically important?
Failure of compatibility may lead to:
- Acute hemolysis
- Acute transfusion reaction
- Acute renal failure
- Shock
- Death
That’s why blood grouping alone is NOT enough!
Types of Cross Matching
- Major Cross Match (Most Important)
Patient serum + Donor RBCs
Any agglutination or hemolysis = Transfusion strictly prohibited
2. Minor Cross Match (Less commonly used today)
Donor serum + Patient RBCs
Mainly relevant in whole blood transfusion
Steps of Cross Matching (In Detail):
First: Preparatory Steps
- ABO & Rh blood grouping (patient and donor)
- Antibody screening for unexpected antibodies
- Verification of sample integrity and blood unit validity
Second: Testing Phases
- Saline Phase
Mixing donor RBCs with patient serum
Detects ABO incompatibility
Agglutination = Immediate rejection - Incubation Phase (37°C)
Incubation for 15–30 minutes
Detects IgG antibodies - AHG Phase (Coombs Phase)
Addition of Anti-Human Globulin
Most critical phase
No reaction = Compatible
Third: Result Interpretation
Agglutination or Hemolysis → Incompatible
No reaction → Compatible – Ready for transfusion
Common Errors to Avoid
- Hemolyzed or contaminated samples
- Mislabeling or patient identification errors
- Ignoring previous transfusion history
- Skipping or shortening test steps
- Relying on blood group only”

Develop your blood knowledge on Hemostasis Today.
-
Jul 12, 2026, 20:44Mary Cushman: Starting ISTH 2026 With Women’s Thrombosis and Hemostasis Health
-
Jul 12, 2026, 20:43Elif Güler Kazanci: Honored to Attend ISTH 2026
-
Jul 12, 2026, 20:41Anna Waterhouse: Exciting First Day at the ISTH 2026
-
Jul 12, 2026, 20:39Ghadir Alkarithi: Exploring the Latest Advances at ISTH 2026
-
Jul 12, 2026, 20:21Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026